Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
67.080,49
0,21%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Neuropace Inc (NPCE) Neuropace Inc (NPCE) Notizie

NPCE

Neuropace (NPCE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NPCE
DataOraFonteTitoloSimboloCompagnia
08/05/202423:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NPCENeuropace Inc
08/05/202422:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NPCENeuropace Inc
05/03/202423:48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NPCENeuropace Inc
29/02/202402:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NPCENeuropace Inc
14/02/202422:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NPCENeuropace Inc
20/12/202323:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NPCENeuropace Inc
19/07/202322:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NPCENeuropace Inc
28/06/202322:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NPCENeuropace Inc
14/06/202323:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NPCENeuropace Inc
04/05/202322:05GlobeNewswire Inc.NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue GuidanceNASDAQ:NPCENeuropace Inc
25/04/202323:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NPCENeuropace Inc
25/04/202323:28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NPCENeuropace Inc
17/04/202322:05GlobeNewswire Inc.NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023NASDAQ:NPCENeuropace Inc
03/04/202322:05GlobeNewswire Inc.NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare ConferenceNASDAQ:NPCENeuropace Inc
02/03/202323:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NPCENeuropace Inc
02/03/202322:05GlobeNewswire Inc.NeuroPace Reports Fourth Quarter & Full Year 2022 Financial ResultsNASDAQ:NPCENeuropace Inc
14/02/202323:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NPCENeuropace Inc
10/02/202319:13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NPCENeuropace Inc
10/02/202314:00GlobeNewswire Inc.NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023NASDAQ:NPCENeuropace Inc
09/01/202322:29Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NPCENeuropace Inc
09/01/202322:03GlobeNewswire Inc.NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of DirectorsNASDAQ:NPCENeuropace Inc
21/12/202222:03GlobeNewswire Inc.NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:NPCENeuropace Inc
30/11/202214:00Business WireNeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now UnderwayNASDAQ:NPCENeuropace Inc
23/11/202223:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NPCENeuropace Inc
21/11/202213:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NPCENeuropace Inc
08/11/202222:29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NPCENeuropace Inc
08/11/202222:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NPCENeuropace Inc
08/11/202222:03GlobeNewswire Inc.NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:NPCENeuropace Inc
04/11/202221:03GlobeNewswire Inc.NeuroPace to Present at the 4th Annual Wolfe Research Healthcare ConferenceNASDAQ:NPCENeuropace Inc
25/10/202222:03GlobeNewswire Inc.NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022NASDAQ:NPCENeuropace Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NPCE

La tua Cronologia

USOTC
MSNVF
Mission Ready Solutions (CE)
USOTC
NDEKY
Nitto Denko (PK)
BIT
RMAU
HANETF The Royal Mint Re...
BOV
P1FG34
Principal Financial
ASX
CHMO
Chimeric Therapeutics
AMEX
BTU-
EU
P539S
P539S
BIT
UB93BG
Unicredit Bank
LBNK
CPLAYUSDT
CPLAY Network
DBI
I1LQ
IN XT SP500 EQW ESGEO H
EU
FR001400LDC6
Societe Generale Societe...
BIT
UB7DJT
Unicredit Bank
DOWI
DJGXARAN
DJ Global ExAustralia Se...
BIT
F15124
Vontobel Financial Produ...
TG
LYQ6
Amundi Euro Government B...
BIT
F17371
Vontobel Financial Produ...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network